Analytical Data
-
基因名
SLFNL1
- Application
-
别名
SLFNL1; Schlafen-like protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q499Z3
-
表达区间
1-407 aa
-
氨基酸序列
MTPMKRSVQT QVSEPFMESW GEESLPELPA EQSLTEYSDL EEAPSAHTLY VGHLNPQFSV PVLACLLRDT LERLEMPVAR EHIEVVRRPR KAYALVQVTV HRDTLASLPW RLQTALEEHL ILKELRGK DLLLSEAQGP FSHREEKEEE EEDSGLSPGP SPGSGVPLPT WPTHTLPDRP QAQQLQSCQG RPSGVCSDSA IVHQQIVGKD QLFQGAFLGS ETRNMEFKRG SGEYLSLAFK HHVRRYVCAF LNSEGGSLLV GVEDSGLVQG IRCSHRDEDR ARLLVDSILQ GFKPQIFPDA YTLTFIPVIS TSETSVPLKV IRLTVHTPKA QSQPQLYQTD QGEVFLRRDG SIQGPLSASA IQEWCRQRWL VELGKLEEKM KALMMEKEQL QQQLQQHGPV SCTCCVL
-
分子量
45.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLFNL1 (Synaptotagmin-like protein family member 1) is a protein that has garnered attention in the field of cellular and molecular biology due to its potential role in neurobiology and cellular signaling. Research into SLFNL1 has been driven by the need to understand its functions and mechanisms, particularly in the context of synaptic transmission and neuronal communication. Initial studies have suggested that SLFNL1 may be involved in regulating synaptic vesicle dynamics and neurotransmitter release, making it a candidate for exploring the molecular underpinnings of synaptic plasticity and neurodevelopmental disorders. Furthermore, its structural characteristics align it with other synaptotagmin-like proteins that participate in Ca²⁺-dependent exocytosis, warranting further investigation into its regulatory pathways. Understanding SLFNL1's interactions with other proteins and its functional implications could provide insights into the pathophysiology of various neurological conditions and guide the development of therapeutic strategies. The recombinant expression of SLFNL1 facilitates the study of its biochemical properties and functional roles, paving the way for innovative research directions in neurobiology and therapeutic interventions. Overall, the SLFNL1 protein represents a promising avenue for advancing our knowledge of synaptic functions and their relevance to health and disease.
